JeanMarie Guenot on the Cutting Edge of Curing Blood Cancers

Jeanmarie Guenot is the President and CEO of Amphivena Therapeutics. She has had more than 20 years of experience in the pharmaceutical industry. Amphivena is involved in creating bifunctional antibody therapies for hematologic malignancies. Jeanmarie Guenot began her career as a Team Leader/Principal Scientist, Preclinical R&D for the Hoffman-La Roche Company in 1993 where she spent three years. She spent another three years at Atlas Venture as an associate in Life Sciences. Guenot went on to become Vice President, Corporate and Business Development at PDL BioPharma for five years. By 2008, Jeanmarie founded Guenot LLC where she served as a manager before heading for SKS Ocular, LLC in 2009 for three years, another company that she had founded.

 

During her career in pharmaceuticals, she worked with treating glaucoma and ocular inflammation therapeutics. Guenot developed Biogen Idec-PDL 50:50 that deals with phase 2 cancer patients. At Amphivena, Dr. Guenot is working on developing antibodies in a first-in-class bi-functional antibody therapy to cure blood cancers. Guenot is trained in physical and medicinal chemistries. She has been trained as a specialist in specialized in drug design, X-ray, quantum mechanical and semi-empirical methods, protein structure and prediction, NMR and refinement. I think that I find Amphibian’s work with cancer treatment the most appealing.

Dr. Guenot can be found on Linkedin and Facebook. People who suffer from hematologic malignancies can benefit most from it because Dr. Guenot has the most up-to-date treatment available. She is working with immunotherapies that help the body to recognize hematological malignancies and attack the cells. The body can learn which cells are not part of the cellular structure of the body and irradiate them. Dr. Geunot can not only treat the body but also supply the right drugs that will be body friendly to the patient while treating these malignancies. I think that being involved in experiments and also in the pharmaceutical area, most patients would find JeanMarie Guenot’s large field of expertise most helpful in seeking treatment for their illnesses.

Read more about her career, and her life’s work here:
https://www.takeda.com/news/2017/20170111_7659.html




Leave a Reply

Your email address will not be published. Required fields are marked *